NCT06097962 2026-03-20Safety and Efficacy of NK510 to Treat NSCLCBase Therapeutics (Shanghai) Co., Ltd.Phase EARLY_PHASE1 Recruiting12 enrolled
NCT05543330 2025-07-20A Phase Ib/II Clinical Trial of M701 in the Treatment of Malignant Pleural Effusions Caused by NSCLCWuhan YZY Biopharma Co., Ltd.Phase 1/2 Recruiting96 enrolled
NCT06740019 2025-04-04A Phase Ib Study of JMKX000197 Injection in the Treatment of Malignant Pleural EffusionJemincarePhase 1 Recruiting30 enrolled
NCT06726564 2024-12-10A Study of MT027 in Patients with Pleural Malignant TumorsSuzhou Maximum Bio-tech Co., Ltd.Phase 1 Recruiting18 enrolled